NCT03705052 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Bar-Sela G, Atid L, Danos S, Gabay N, Epelbaum R
Art therapy improved depression and influenced fatigue levels in cancer patients on chemotherapy. Psychooncology. 2007 Nov;16(11):980-4.
Geue K, Goetze H, Buttstaedt M, Kleinert E, Richter D, Singer S
An overview of art therapy interventions for cancer patients and the results of research. Complement Ther Med. 2010 Jun-Aug;18(3-4):160-70. doi: 10.1016/j.ctim.2010.04.001. Epub 2010 May 15. Review.
Visser A, Op 't Hoog M
Education of creative art therapy to cancer patients: evaluation and effects. J Cancer Educ. 2008;23(2):80-4. doi: 10.1080/08858190701821204.
Walsh SM, Martin SC, Schmidt LA
Testing the efficacy of a creative-arts intervention with family caregivers of patients with cancer. J Nurs Scholarsh. 2004;36(3):214-9.

Patient's and Caregiver's Expectations and Preferences Concerning Art Therapy Activities for Cancer Support in Light of Founding an Art Therapy Centre

Details for clinical trial NCT03705052

Clinical trial NCT03705052 - References